CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese

BACKGROUND: Previous studies suggest gliclazide is metabolised primarily by CYP2C19 rather than CYP2C9, unlike other sulphonylureas. CYP2C19 *2 and *3 polymorphisms are more common in Asians. METHODS: We investigated the effect of CYP2C19 polymorphisms on gliclazide pharmacokinetics in 15 healthy ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Elaine, Poon, Emily WM, Fok, Benny SP, Chan, Juliana CN, Tomlinson, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997415/
https://www.ncbi.nlm.nih.gov/pubmed/32099442
http://dx.doi.org/10.2147/PGPM.S226200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997415/
https://www.ncbi.nlm.nih.gov/pubmed/32099442
http://dx.doi.org/10.2147/PGPM.S226200

Ejemplares similares